Skip to main content
. Author manuscript; available in PMC: 2022 May 6.
Published in final edited form as: Cardiol Cardiovasc Med. 2022 Apr 12;6(2):137–156. doi: 10.26502/fccm.92920251

Figure 5:

Figure 5:

Representative images for the mitochondrial pore transition staining: (A) control SMCs and carotid SMCs treated with LPS, LDL and oxLDL. Images in the left panel represent the nuclei, second panel represents MitoTracker red staining, third panel represents calcein staining and the right panel shows overlay staining with DAPI. Images in the top row of each panel show control cells, second row displays LPS group, third row represents LDL treatment, and the fourth row shows oxLDL treatment. The images were acquired at 40x magnification. (B) The quantification of MitoTracker red and calcein staining where the graph represents mean values with standard error. The statistical significance based on one-way ANOVA test is represented in the figure (*** P<0.001, * P<0.05, # LPS vs LDL for calcein, $ LPS vs LDL for MitoTracker and NS - non-significant).